According to Biotest 's latest financial reports the company's current EPS (TTM) is -0,25 โฌ. In 2022 the company made an earnings per share (EPS) of -0,78 โฌ an increase over its 2021 EPS that were of -1,70 โฌ.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -0,29 โฌ | -62.64% |
2022 | -0,78 โฌ | -54.27% |
2021 | -1,70 โฌ | 99.36% |
2020 | -0,85 โฌ | 471.15% |
2019 | -0,15 โฌ | -103.03% |
2018 | 4,92 โฌ | -9663.05% |
2017 | -0,05143 โฌ | -95.43% |
2016 | -1,13 โฌ | -47.94% |
2015 | -2,16 โฌ | -468.28% |
2014 | 0,59 โฌ | -42.66% |
2013 | 1,02 โฌ | -8.51% |
2012 | 1,12 โฌ | -31.45% |
2011 | 1,63 โฌ | 30.12% |
2010 | 1,25 โฌ | 36.09% |
2009 | 0,92 โฌ |